INTRODUCTION AND OBJECTIVES: As the Father of Urologic
Oncology, Dr. Willett F. Whitmore Jr presided over a dynamic period regarding the diagnosis and treatment of prostate cancer. His commitment to evidence based medicine is documented in many publications involving clinical research of prostate cancer, and was verified in his daily practice. Using a "Four Question" approach to the natural history of prostate cancer, he defined critical selection criteria for therapeutic intervention versus observation based on the likelihood of morbidity and mortality. We review his contributions, which created the foundation of the modern era of conservative management of prostate cancer.
METHODS: A comprehensive literature review and internet search concerning Dr. Whitmore's observations and approach to prostate cancer management.
RESULTS: One hundred years after the first description of prostate cancer and on the eve of the discovery of DNA in 1953, Dr. Whitmore described the natural history of prostate cancer. He noted that not all disease was clinically significant but hypothesized an "unknown activating power to release its malignant potential." Three years later, he published on the role of hormone therapy in prostate cancer applying a novel alphabetical staging system, as well as considerations for patient age and life expectancy. This Whitmore staging system was later revised to include subclassifications yielding the Whitmore-Jewett staging system, the pre-eminent American staging system until TNM staging in 1992. In 1974, he published his observations, updated with the incorporation of tumor grading, on the variability of prostate cancer progression and mortality in Lancet. Despite clinical and research experience with androgen deprivation therapy, and the popularity of prostatic brachytherapy and nerve-sparing radical prostatectomy, he remained an advocate for active surveillance and watchful waiting. The era of the adoption of PSA screening and widespread use of ultrasound guided prostate biopsy was marked by a 3-fold increase in rates of radiation and prostatectomy for prostate cancer. Throughout this time, he continued to ask, "If cure is necessary, is it possible, and if cure is possible, is it necessary?" At the age of 74, he was diagnosed with prostate cancer and ultimately pursued a conservative management course, a final testament to his convictions regarding prostate cancer treatment, which are now the standard of care.
CONCLUSIONS: Dr. Willett F. Whitmore Jr. was a progressive, evidence-based proponent of active surveillance in prostate cancer in an intervention driven era of aggressive management. It is estimated that 20 million gallons were sprayed by helicopters and trucks during this time. Agent Orange was used as a defoliant to diminish cover for the Viet Cong and decrease crop supplies. It is made of two phenoxy compounds, one of which contains a dioxin compound (TCDD). TCCD has been shown to be a human carcinogen. The term "Agent Orange" comes from the orange stripe that marked it's storage barrels. As the Vietnam War progressed, Agent Orange was targeted at civilian crops resulting in malnourishment and starvation. The United Nations tried to pass a resolution in 1966 to stop the use of this chemical weapon, however the United States defeated this measure by labeling it an herbicide. METHODS: Sources were attained from Pubmed using the words "agent orange" and "urologic cancers" and historical texbooks.
RESULTS: Agent Orange's effect on the environment and health of the Vietnamese and American soldiers was significant. Approximately, 20% of South Vietnamese forests were sprayed during the campaign. Agent Orange destroyed 5 x 1,000,000 acres of forests and thousands of acres of crops. The Vietnamese estimate that 4 million citizens were exposed to Agent Orange. Elevated levels of dioxin was found in blood samples and breast milk of Vietnamese. High levels of dioxin have been found near US airbases and storage sites where Agent Orange was kept. The Vietnamese have cited increase in the number birth defects -including cleft palate, spina bifida and neural defects. American soldiers, especially ground troops and helicopter airman were high risk for exposure. There have been reports of men using the Agent Orange barrels for washing.
The US government began tracking the effects of Agent Orange on veterans in the 1990's. The latest update was reported in 2016. There appears to be direct evidence that Agent Orange causes sarcoma, NHL and CLL. There is suggestive evidence that it causes lung cancer, prostate and bladder cancer. The Michigan VA study in 2004 showed men with prostate cancer had a two time increased likelihood of exposure to Agent Orange. The Portland VA study showed an increase risk of high grade prostate cancer in men exposed to Agent Orange. Similarly, there have been studies linking Agent Orange to bladder cancer in veterans.
CONCLUSIONS: Since 1991, the VA has been compensating Veterans who develop illness related to Agent Orange. In 2011, the United States committed 32 million dollars to clean up dioxin contamination in Vietnam. Although the war ended in 1975, the effects of Agent Orange continues to haunt the survivors. "Once upon a time" e that is until the 1970s, the treatment of BPH was based on surgery. If the world of urology were to resemble Cinderella, then Prof. Marco Caine was definitely her prince! METHODS: His innovations were revolutionary, demonstrating that by treating LUTS, such as frequency, weak flow and large residual volume with alpha blockers, he could improve the quality of the patients' life and, in many cases, negate the need for surgical intervention. This literally "opened Cinderella's eyes", after which the number of prostate operations for BPH declined dramatically. By the late 1990s the talk was that with further developments of different alpha blockers and 5 alpha reductase agents, there would be no need for surgery at all. Whilst this has not entirely transpired, the revolution from purely surgical treatment to almost only pharmacological care was completed, similar to the care of peptic disease which moved from the surgical to H2 blockers and PPIs.
RESULTS: Born in the UK, he grew up as a gifted violinist, but fate took him in another direction. He finished his medical studies in London in 1945 and subsequently urology in 1953.
Early on his innovations in the field of Cine Radiology made him a "founding-father" of Urodynamics, making him one of the first pioneers and marked him as a meteor within the community. This led to his receiving the prestigious MS (master of surgery) from the University of London and civil recognition when he was awarded the Freeman of the City of London. Vol. 201, No. 4S, Supplement, Friday, May 3, 2019 THE JOURNAL OF UROLOGY Ò e251
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